(Q39530598)

English

Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting

scientific article published on September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

anti-retroviral agent

0 references

0 references

Eugenia Quiros-Roldan

4

object named as

Eugenia Quiros-Roldan

0 references

author name string

Carlo Torti

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Salvatore Casari

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Loredana Palvarini

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Francesca Moretti

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Luigi Leone

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Andrea Patroni

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Francesco Castelli

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Diego Ripamonti

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Andrea Tramarin

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Giampiero Carosi

11

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

261-267

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hospitalizations and Costs of Treatment for Protease Inhibitor-Based Regimens in Patients with Very Advanced HIV-Infection (CD4 < 50/mm3)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost effectiveness of combination antiretroviral therapy for HIV disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic impact of HIV protease inhibitor therapy in the global use of health-care resources

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The Cost Effectiveness of Antiretroviral Therapy for HIV Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of combination HIV therapy: 3 years later

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. February 5, 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly active antiretroviral therapy: pharmacoeconomic issues in the management of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8510(03)00002-2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39530598&oldid=1836117321"